David E. Elder

5.2k total citations · 1 hit paper
78 papers, 3.4k citations indexed

About

David E. Elder is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, David E. Elder has authored 78 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 22 papers in Molecular Biology and 13 papers in Epidemiology. Recurrent topics in David E. Elder's work include Cutaneous Melanoma Detection and Management (59 papers), Melanoma and MAPK Pathways (16 papers) and Cancer Genomics and Diagnostics (12 papers). David E. Elder is often cited by papers focused on Cutaneous Melanoma Detection and Management (59 papers), Melanoma and MAPK Pathways (16 papers) and Cancer Genomics and Diagnostics (12 papers). David E. Elder collaborates with scholars based in United States, France and Australia. David E. Elder's co-authors include Richard A. Scolyer, Daniela Massi, Wallace H. Clark, DuPont Guerry, Rein Willemze, Boris C. Bastian, Allan C. Halpern, Raymond L. Barnhill, Ian A. Cree and Meenhard Herlyn and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

David E. Elder

76 papers receiving 3.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway

2020 304 citations David E. Elder, Boris C. Bastian et al. Archives of Pathology & Laboratory Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
David E. Elder	2.4k	1.2k	836	593	532	78	3.4k
Douglas R. Fullen	3.6k 1.5×	2.1k 1.8×	616 0.7×	674 1.1×	585 1.1×	130	5.5k
Toshiaki Saida	2.6k 1.1×	1.6k 1.4×	1.5k 1.8×	1.3k 2.2×	666 1.3×	182	4.7k
Thomas Wiesner	1.9k 0.8×	1.7k 1.4×	519 0.6×	363 0.6×	375 0.7×	54	4.0k
Rosalie Elenitsas	2.6k 1.1×	1.1k 0.9×	1.8k 2.2×	1.4k 2.4×	363 0.7×	163	4.9k
Pedram Gerami	3.7k 1.5×	2.4k 2.0×	1.3k 1.6×	1.3k 2.2×	483 0.9×	198	5.5k
Caterina Catricalà	1.6k 0.6×	639 0.5×	1.0k 1.2×	932 1.6×	342 0.6×	74	2.7k
K Hou-Jensen	1.4k 0.6×	927 0.8×	683 0.8×	416 0.7×	207 0.4×	87	3.4k
W. H. Clark	1.8k 0.8×	1.0k 0.8×	343 0.4×	311 0.5×	345 0.6×	19	2.6k
Jeffrey P. North	1.5k 0.6×	1.1k 0.9×	452 0.5×	294 0.5×	236 0.4×	93	2.5k
Toshiro Kageshita	2.8k 1.2×	2.9k 2.4×	431 0.5×	369 0.6×	600 1.1×	135	5.1k

Countries citing papers authored by David E. Elder

Since Specialization

Citations

This map shows the geographic impact of David E. Elder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Elder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Elder more than expected).

Fields of papers citing papers by David E. Elder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Elder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Elder. The network helps show where David E. Elder may publish in the future.

Co-authorship network of co-authors of David E. Elder

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Elder. A scholar is included among the top collaborators of David E. Elder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Elder. David E. Elder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mitchell, Tara C., David E. Elder, Phyllis A. Gimotty, et al.. (2024). Tumor-Infiltrating Lymphocytes in Necrotic Tumors after Melanoma Neoadjuvant Anti–PD-1 Therapy Correlate with Pathologic Response and Recurrence-Free Survival. Clinical Cancer Research. 30(21). 4987–4994. 1 indexed citations

Nickel, Brooke, David E. Elder, Peter M. Ferguson, et al.. (2024). Impact of alternative diagnostic labels for melanoma in situ on management choices and psychological outcomes: protocol for an online randomised study. BMJ Open. 14(12). e089558–e089558. 2 indexed citations

Elder, David E.. (2024). Melanoma Diagnosis in the Mihm Era—And Beyond. Journal of Cutaneous Pathology. 53(1). 16–22. 2 indexed citations

Kerr, Kathleen F., David E. Elder, Michael W. Piepkorn, et al.. (2023). Pathologist Characteristics Associated With Rendering Higher-Grade Diagnoses for Melanocytic Lesions. JAMA Dermatology. 159(12). 1315–1315. 5 indexed citations

Eguchi, Megan, David E. Elder, Raymond L. Barnhill, et al.. (2022). Prognostic modeling of cutaneous melanoma stage I patients using cancer registry data identifies subsets with very‐low melanoma mortality. Cancer. 129(1). 89–97. 15 indexed citations

Kerr, Kathleen F., Megan Eguchi, Michael W. Piepkorn, et al.. (2022). Dermatopathologist Perceptions of Overdiagnosis of Melanocytic Skin Lesions and Association With Diagnostic Behaviors. JAMA Dermatology. 158(6). 675–675. 9 indexed citations

Elmore, Joann G., Megan Eguchi, Raymond L. Barnhill, et al.. (2022). Effect of Prior Diagnoses on Dermatopathologists’ Interpretations of Melanocytic Lesions. JAMA Dermatology. 158(9). 1040–1040. 8 indexed citations

Piepkorn, Michael W., Megan Eguchi, Raymond L. Barnhill, et al.. (2022). Reproducibility of the histopathologic diagnosis of melanoma and related melanocytic lesions: Results from a testing study and a reference guide for providers. JAAD International. 9. 7–10. 6 indexed citations

Elder, David E., Boris C. Bastian, Ian A. Cree, Daniela Massi, & Richard A. Scolyer. (2020). The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway. Archives of Pathology & Laboratory Medicine. 144(4). 500–522. 304 indexed citations breakdown →

10.

Elder, David E., Daniela Massi, Richard A. Scolyer, & Rein Willemze. (2018). WHO classification of skin tumours. 274 indexed citations

11.

Sinnamon, Andrew J., Yun Song, Yu‐Xiao Yang, et al.. (2018). Prediction of Residual Nodal Disease at Completion Dissection Following Positive Sentinel Lymph Node Biopsy for Melanoma. Annals of Surgical Oncology. 25(12). 3469–3475. 11 indexed citations

12.

Lott, Jason P., Denise M. Boudreau, Martin A. Weinstock, et al.. (2017). Population-Based Analysis of Histologically Confirmed Melanocytic Proliferations Using Natural Language Processing. JAMA Dermatology. 154(1). 24–24. 49 indexed citations

13.

Xu, Xiaowei, Phyllis A. Gimotty, DuPont Guerry, Giorgos C. Karakousis, & David E. Elder. (2013). Lymphatic Invasion as a Prognostic Biomarker in Primary Cutaneous Melanoma. Methods in molecular biology. 1102. 275–286. 16 indexed citations

14.

Gerami, Pedram, Chelsea Cooper, Shirin Bajaj, et al.. (2013). Outcomes of Atypical Spitz Tumors With Chromosomal Copy Number Aberrations and Conventional Melanomas in Children. The American Journal of Surgical Pathology. 37(9). 1387–1394. 65 indexed citations

15.

Barnhill, Raymond L., Lorenzo Cerroni, Martin Cook, et al.. (2010). State of the Art, Nomenclature, and Points of Consensus and Controversy Concerning Benign Melanocytic Lesions: Outcome of an International Workshop. Advances in Anatomic Pathology. 17(2). 73–90. 46 indexed citations

16.

Zhang, Paul J., Theresa L. Pasha, Rosalie Elenitsas, et al.. (2004). Expression of Melan-A and Ki-67 in Desmoplastic Melanoma and Desmoplastic Nevi. American Journal of Dermatopathology. 26(6). 452–457. 48 indexed citations

17.

Lyle, Stephen, David E. Elder, Melpo Christofidou‐Solomidou, et al.. (1999). Human Hair Follicle Bulge Cells are Biochemically Distinct and Possess an Epithelial Stem Cell Phenotype. Journal of Investigative Dermatology Symposium Proceedings. 4(3). 296–301. 108 indexed citations

18.

Clemente, Claudio, Alistair J. Cochran, David E. Elder, et al.. (1991). Histopathologic diagnosis of dysplastic nevi: Concordance among pathologists convened by the world health organization melanoma programme. Human Pathology. 22(4). 313–319. 111 indexed citations

19.

Clark, Wallace H., et al.. (1990). Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. Journal of the American Academy of Dermatology. 22(6). 1042–1048. 153 indexed citations

20.

Elder, David E. & Meenhard Herlyn. (1990). Antigens Associated with Tumor Progression in Melanocytic Neoplasia. Pigment Cell Research. 3(S2). 136–143. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact